Page last updated: 2024-08-21

evans blue and Coronary Disease

evans blue has been researched along with Coronary Disease in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19904 (36.36)18.7374
1990's4 (36.36)18.2507
2000's3 (27.27)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CASTER, WO; GARAMELLA, JJ; NAIDU, R; VELOSO, A1
Crockett, TR; Gray, GA; Kane, KA; Wainwright, CL1
Rydén, L; Shimizu, M; Sjöquist, PO; Wang, QD1
Bissing, JW; Kerber, RE; Ryan, AJ1
Camarano, G; Freidlin, RZ; Jones, M; Panza, JA1
Abrahamsson, T; Johansson, MH; Sjöquist, PO1
Garaev, GSh; Ismailova, ZD; Mamedov, IaD; Mirzabekova, FI1
Bergman, AH; de Roos, A; Doornbos, J; Matheijssen, NA; Mohanlal, RW; van der Laarse, A; van der Wall, EE; van Vaals, JJ1
Krause, W; Maass, B; Mueller, B; Witt, W1
Gatsura, VV; Sernov, LN1
Bernauer, W1

Other Studies

11 other study(ies) available for evans blue and Coronary Disease

ArticleYear
Effect of acute coronary occlusion upon the movement of Evans blue dye into different areas of pig heart muscle.
    American heart journal, 1958, Volume: 56, Issue:5

    Topics: Animals; Coronary Disease; Coronary Occlusion; Coronary Vessels; Evans Blue; Heart; Humans; Myocardium; Swine

1958
Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2

    Topics: Animals; Blood Pressure; Coronary Disease; Disease Models, Animal; Drug Administration Schedule; Evans Blue; Glyceraldehyde-3-Phosphate Dehydrogenases; Injections, Intravenous; Ligation; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Time Factors; Ventricular Fibrillation; Viper Venoms

2004
Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
    Journal of cardiovascular pharmacology, 1999, Volume: 34, Issue:4

    Topics: Anesthesia; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Antioxidants; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Coronary Disease; Drug Synergism; Drug Therapy, Combination; Evans Blue; Felodipine; Female; Hemodynamics; Indoles; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Perfusion; Random Allocation; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Swine; Terphenyl Compounds; Tetrazoles

1999
Coronary risk area measurement by intracardiac echocardiography and ultrasound contrast.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2001, Volume: 14, Issue:7

    Topics: Animals; Coloring Agents; Contrast Media; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Echocardiography; Evans Blue; Myocardial Infarction; Observer Variation; Reproducibility of Results; Risk Factors; Swine

2001
Quantitative assessment of left ventricular perfusion defects using real-time three-dimensional myocardial contrast echocardiography.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2002, Volume: 15, Issue:3

    Topics: Animals; Coloring Agents; Coronary Disease; Coronary Vessels; Echocardiography, Three-Dimensional; Evans Blue; Models, Animal; Sheep; Ventricular Function, Left

2002
Time course of regional flow distribution following reperfusion of the isolated ischaemic rat heart.
    Clinical and experimental pharmacology & physiology, 1992, Volume: 19, Issue:4

    Topics: Animals; Coronary Circulation; Coronary Disease; Evans Blue; In Vitro Techniques; Male; Microspheres; Myocardial Reperfusion; Rats; Rats, Inbred Strains; Time Factors

1992
[Stimulation of cardiac lymphatic drainage by obzidan, heparin and rheogluman in acute myocardial ischemia].
    Biulleten' eksperimental'noi biologii i meditsiny, 1990, Volume: 110, Issue:11

    Topics: Acute Disease; Animals; Coronary Disease; Dextrans; Dogs; Drug Combinations; Drug Evaluation, Preclinical; Evans Blue; Female; Heart; Heparin; Lymphatic System; Male; Mannitol; Propranolol; Stimulation, Chemical; Time Factors

1990
Gadolinium-DTPA-enhanced magnetic resonance imaging of the isolated rat heart after ischemia and reperfusion.
    Investigative radiology, 1991, Volume: 26, Issue:12

    Topics: Animals; Contrast Media; Coronary Disease; Evans Blue; Gadolinium DTPA; In Vitro Techniques; Magnetic Resonance Imaging; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Rats

1991
Limitation of myocardial unperfused area and necrotic zone 24 hours and 7 days after coronary artery ligation in rats by the stable prostacyclin analogue iloprost.
    Prostaglandins, leukotrienes, and medicine, 1986, Volume: 21, Issue:3

    Topics: Animals; Blood Pressure; Coronary Disease; Coronary Vessels; Epoprostenol; Evans Blue; Follow-Up Studies; Iloprost; Infusions, Intra-Arterial; Ligation; Male; Myocardium; Perfusion; Platelet Aggregation; Rats; Rats, Inbred Strains; Tissue Distribution

1986
[The differential indicator method of determining the areas of ischemia and necrosis in experimental myocardial infarct in rats].
    Biulleten' eksperimental'noi biologii i meditsiny, 1989, Volume: 107, Issue:5

    Topics: Animals; Coronary Disease; Evans Blue; Formazans; Male; Mathematics; Myocardial Infarction; Myocardium; Necrosis; Rats; Staining and Labeling

1989
Inhibiting effect of dexamethasone on evolving myocardial necrosis in coronary-ligated rats, with and without reperfusion.
    Pharmacology, 1985, Volume: 31, Issue:6

    Topics: Animals; Coronary Disease; Dexamethasone; Evans Blue; Ligation; Male; Myocardium; Necrosis; Perfusion; Rats; Rats, Inbred Strains; Time Factors

1985